Fostering innovation, generating new knowledge and ideas. Working with the infectious disease community worldwide to promote collaboration among researchers. Enabling investigators to extend their research experience, learning, and sharing inside and outside their region. Supporting infectious disease professionals to develop their skills, conduct groundbreaking scientific research, and expand their horizons.
Professional development opportunities and funding for original scientific research.
Questions and requests for additional information about any of the following grants should be directed to: firstname.lastname@example.org.
ISID’s research grants are one of the Society’s signature programs and are instrumental in fulfilling ISID’s commitment to funding researchers from countries which bear the greatest burden of infectious disease. To date over 175 grants have been awarded to infectious diseases researchers from 46 countries.
Up to eight grants of up to US$7,000 each will be awarded annually and are available to support the professional development of young investigators working in the field of human infectious diseases by funding pilot research projects to be carried out over the course of a year at the applicant’s institution. Areas of interest include, but are not limited to:
Grants that address the following AMR issues will be given priority:
Upon completion of their research, additional funding may also be available for recipients to attend an ISID event to present their findings, either at the International Congress on Infectious Diseases or the International Meeting on Emerging Diseases and Surveillance.
The highest ranked research proposal will receive the Norman Stein Research Grant named in honor ISID’s Executive Director from 1986-2017.
ISID’s research grant applications are open to residents of low or lower-middle income countries as classified by the World Bank, who are less than forty years of age, who have not previously had the opportunity to work or study outside of their region, or received major research funding including ISID grants.
Applications should be made using our online submissions system by April 1st and include:
Upon completion, a short written report on the outcomes of research must be submitted to the Society. ISID also encourages recipients of grants to present their results at scientific meetings and to submit them for publication in peer-reviewed journals including, but not limited to, the International Journal of Infectious Diseases.
Proposals will be reviewed by experts in the field of infectious diseases chosen by the Society and grants awarded by ISID’s Research Committee in collaboration with the ISID research program’s director and manager.
The International Society for Infectious Diseases (ISID) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) established their joint fellowship program in 2010 to foster international, peer-to-peer collaboration and the exchange of scientific knowledge and best practice. The program enables young investigators, from low and low-middle income countries outside of the region, to travel to Europe for multidisciplinary clinical and laboratory training.
In the formative stages of their careers, successful applicants are given the opportunity to extend their research experience; learn from experienced infectious disease specialists; and return home with knowledge and processes that will help them improve clinical practice in regions where it most needs strengthening. With this objective in mind, proposals that enhance the transfer of technologies to geographical areas where they are particularly needed are favored.
Two fellowships of up to US$7,500 and up to three months in duration are awarded annually.
ISID/ESCMID fellowships are open to residents of low and low-middle income countries, as classified by the World Bank, from outside of Europe, who are less than forty years of age, and will benefit from the opportunity to work or study outside of their country of residence.
Applications should be made using our on-line submission system by April 1st and include:
Upon completion, a short written report on the outcomes of any research must be submitted. ISID and ESCMID also encourage recipients of grants to present their results at scientific meetings and to submit them for publication in peer-reviewed journals including, but not limited to, the International Journal of Infectious Diseases.
Proposals will be reviewed by members of ISID’s Research Committee and grants awarded in collaboration with ISID and ESCMID’s research program directors.
ISID and the Swiss Society for Infectious Diseases (SSI) jointly sponsor the SSI/ISID Infectious Diseases Research Fellowship Program.
The purpose of this Fellowship Program is to support infectious disease physicians and scientists from under-resourced countries through multidisciplinary clinical and laboratory training at select biomedical institutions in Switzerland. The objectives of the Fellowship Program are:
Opportunities for training and research in a variety of areas ranging from basic studies of the mechanism of disease to studies in public health, epidemiology, diagnostics, therapeutics or vaccine development, are available through this program.
The term of the Fellowship is for one year. The start date of the will be determined by arrangement between the host institution and the Fellow.
A financial stipend of up to 36,000 SF per year (approximately $35,500 USD) will be given to Fellows to cover travel costs and living expenses. The program intends to award two fellowships every year.”
SI/ISID fellowships are open to residents of low and middle income countries as classified by the World Bank https://datahelpdesk.worldbank.org/knowledgebase/articles/906519 who have either a M.D. or Ph.D. in a relevant field and hold a position at a medical, research or public health institution.
NOTE: Applicants are required to be proficient in writing and speaking English and either German (for Basel, Bern, Zurich and St. Gallen) or French (for Geneva and Lausanne). Applicants who propose a research-only fellowship do not need French or German fluency.
Applications should be made using our online submissions system https://www.eiseverywhere.com/eSites/223060/Homepage and include:
The annual deadline for applications is April 1st.
Applications will be reviewed by a joint SSI/ISID committee.
SSI/ISID Fellows will be placed at one of six collaborating research centers in Switzerland according to technical interests and skills. All infectious diseases programs at each institution offer experience in clinical infectious diseases, including HIV, and microbiology.
The technical research interests at each site include:
Infectious diseases and Hospital epidemiology. Full clinical service in all areas of infectious diseases and hospital epidemiology; Pathophysiologal and clinical research including health economy in following aereas: HIV clinical and pharmacological research in collaboration with Ifakara, Tansania and Lesotho, Subsaharan Africa and the Swiss HIV Cohort Study Group: pathogenesis and course of disease in transplant infectious diseases, Hospital Epidemiology.
(Battegay M, Widmer A, Khanna N, Tschudin Sutter S, Weisser M, Labhardt N, Stoeckle M, Marzolini C)
For clinical work excellent language skills in German (oral and written) are mandatory and for research English is a requirement.
The strength of our center is that we provide a functional combination of ID service, hospital infection control and comprehensive microbiology laboratory covering all aspects of infectious diseases at the largest hospital group of Switzerland (Insel Group Hospitals) with daily interactions of all involved specialties and laboratories on a daily basis for improved patient care.
The ID department (www.infektiologie.insel.ch) has three overlapping services: ID Consultation Service (3 teams 7x24hrs) for all departments and specialties in a tertiary-care academic hospital with daily rounds in ICU and neutropenia wards. The ID department has no ID ward or ID beds, but performs ID consultation on all hospital wards. Additional consultation services on demand in the other hospitals belonging to the Insel Group (www.insel.ch). Outpatient ID Clinic including general ID outpatient service and a special focus on HIV medicine and STDs; travel, tropical and migration medicine; and consultations within the city´s drug substitution – harm reduction programs. Infection prevention unit: Infection control and hospital epidemiology service for the entire Insel Group.
The Institute for Infectious Diseases (http://www.ifik.unibe.ch) is the only university institute in Switzerland covering the entire spectrum of microbiology, including virology, bacteriology, mycology, parasitology, molecular diagnostic and infection serology integrated in comprehensive diagnostic services, research, and education. The IFIK provides the entire spectrum of microbial diagnostic services for patient care in private practices and public hospitals including the Insel Group, the largest hospital group in Switzerland. The diagnostic service is recognized by the regulatory body Swissmedic and accredited according ISO/IEC 17025, (STS 0363). The IFIK is home to the Swiss National Reference Centre for Pneumococci and to the Swiss National Centre for Antibiotic Resistance (www.anresis.ch) mandated by the Federal Office of Public Health.
The ID department’s research focuses on clinical aspects and epidemiology of infectious diseases. Lab facilities are in the partner Institute for Infectious Diseases (IFIK). We conduct collaborative research involving the entire spectrum of infectious diseases with our clinical partners within the Insel Group (S. Zimmerli, C. Thurnheer, C. Hirzel). HIV infection is one of our main areas of research. We lead many research projects within the framework of the Swiss HIV Cohort Study (www.shcs.ch) and international collaborations. Main focuses are HIV/ Hepatitis co-infections (A. Rauch, G. Wandeler, C. Béguelin), both in the European and the African context, opportunistic infections (H. Furrer), STDs (C.Hauser) and migration and HIV (C. Staehelin).
Another research focus is infection control and hospital epidemiology (J. Marschall, R. Sommerstein, N. Buetti), with research projects inside the Insel Goup and country-wide within the Swissnoso framework (www.swissnoso.ch).
We are involved in the research of the Swiss Transplant Cohort Study (www.stcs.ch) (C. Hirzel, L. Walti).
At the Institute for Infectious Diseases (http://www.ifik.unibe.ch) the 3 major research focuses are antimicrobial resistance, infections of the central nervous system, and host-microbiome interactions and infections of the intestine and airways. (http://www.ifik.unibe.ch/forschung/index_ger.html)
For clinical work very good language skills in German (oral and written) and French (oral) are mandatory and for research English is a requirement.
General clinical infectious diseases in adults. Access to specific expertise or units specialized in HIV, infections in transplant patients, antibiotic stewardship or emerging viruses. Access to clinical microbiology labs and possibilities to participate to clinical research. Close collaborations with other Divisions specialized in Tropical Medicine, Infection Control or Pediatrics.
(Kaiser L, A Calmy, Schrenzel J, van Delden C, B Huttner, S Harbarth)
For clinical work excellent language skills in French (oral and written) are mandatory and for research English is a requirement.
Additional information is available at: https://www.hug-ge.ch/maladies-infectieuses
Antibiotic stewardship. Monitoring of antibiotic use. Outpatient antibiotic therapy. Diagnosis and management of community-acquired pneumonia. Complicated bone and joint infections. Surgical implant associated-infections. Septic surgery. Diagnostic microbiology (MALDI-TOF, automation, molecular diagnosis). Infections in immunocompromised hosts. Transplant infectious diseases, vaccination in immunocompromised patients. Innate immunity. Sepsis. Immunogenetics of infectious diseases and genetic epidemiology. Infections in critically-ill and ICU patients. Ventilator associated pneumonia, Pseudomonas aeruginosa. Invasive fungal infections. Molecular epidemiology of nosocomial infections. Emerging infections. Infections due to intracellular bacteria (Chlamydiae, Coxiella…). Clostridium difficile, fecal microbiota transplantation. HIV medicine (neuro-HIV, adherence). Pediatric infectious diseases and vaccinology (infections among immunocompromised patients, children with cystic fibrosis). Congenital infections (cCMV). Malaria. Travel medicine and vaccinology.
(Asner S, Bochud PY, Boillat-Blanco N, Calandra T, Cavassini M, de Valliere S, Galperine T, Genton B, Giulieri S, Greub G, Guery B, Lamoth F, Manuel O, Roger T, Senn L, Zanetti G)
For clinical work very good language skills in French (oral and written) are mandatory and for research English is a requirement.
Clinical trials in HIV. Molecular biology of HIV, latent reservoirs, and anti-HIV immune response. HIV epidemiology. Intestinal infections. Zoonotic infections. Hospital epidemiology.
(Weber R, Ruef C, Guenthart H, Opravil M, Trkola A, Flepp M, Speck R, Ledergerber B)
Department of Infectious Diseases and Hospital Epidemiology: http://www.en.infektiologie.usz.ch/
In a world with ever increasing population mobility, emerging and re-emerging infectious diseases have the potential to spread to new geographic locations and new populations at pace. Combating the threat they pose with effective infectious disease diagnosis, containment, and treatment is a global priority. It is crucial that new generations of infectious disease specialists have an understanding of infectious diseases that may not be prevalent in their communities; that they become promoters of international collaborations and multi-national clinical and/or translational research initiatives; and become members of regional ID networks.
ISID’s Short Term Exchange Program (STEP) is an initiative which supports international, regional collaboration by giving current infectious disease fellows the opportunity to rotate to an institution outside of their country of residence but within their region. It is hoped that the relationships built and knowledge gained by recipients will be transferred to their home institutions, strengthening the infectious disease specialty and partnerships.
South America was selected as the pilot for the program’s launch to coincide with the 18th International Congress on Infectious Diseases that took place in Buenos Aires, Argentina, in March 2018. The 2019 region will be announced before the end of 2018. Fellowships of up to US $5,000 and 2-4 months in duration are available.
STEP Fellowships are open to clinicians to who are forty years of age or less; who are already fellows in clinical adult or pediatric infectious disease programs in the selected region; and who are proposing to rotate to an academic center outside of their country of residence to another country in the same selected region.
Applications should be made using our online submission system and include:
Individual’s submitting applications are responsible for securing invitations and making all necessary arrangements.
Applications will be evaluated and scored by members of ISID’s External Affairs and Research Committees based on the expected benefits of the rotation including: clinical, research or other skills to be obtained; envisioned collaborations; and support for the exchange from associated institutions.
In 2017, the Center for Diseases Dynamics, Economics & Policy (CDDEP), an organization with expertise in antimicrobial resistance (AMR), partnered with ISID to provide senior mentors for AMR-topic awardees.
Dr. Patricio Acosta, Argentina
The National Scientific and Technical Research Council (CONICET)
A role for interferon in vulnerable children with influenza
Mr. Daniel Asfaw Erku, Ethiopia
University of Gondar
Implementing community pharmacy-based antimicrobial stewardship program in Gondar town, Ethiopia: implication to promote rational use of antibiotics in the community
CDDEP Mentor: Dr. Estelle Mbadiwe
Dr. Tehmine Harityunyan, Armenia
Department of Zoology, Yerevan State University
The first molecular epidemiological survey to study Lyme disease pathogens in ticks of Armenia
Dr. Emmanuel Irek, Nigeria
Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria
Carbapenem-resistant enterobacteriaceae surveillance in Obafemi Awolowo Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria
CDDEP Mentor: Dr. Olga Perovic
Dr. Sulaiman Lakoh, Sierra Leone
Ministry of Health and Sanition, Government of Sierra Leone
Healthcare-associated infections (HAI) and antibiotic prescription and use in hospitalized patients at Connaught Hospital, Freetown, Sierra Leone
CDDEP Mentor: Dr. Eili Klein
Dr. Shruti Murthy, India
Economic burden of neonatal systemic infections in South Karnataka, India
Dr. Temitope Oyewole Obadare, Nigeria
Obafemi Awolowo University Teaching Hospitals Complex Ile-Ife, Osun State, Nigeria
Characterisation of neonatal sepsis in a tertiary hospital, South-West, Nigeria
CDDEP Mentor: Dr. Abhilasha Karki
Dr. Sofiya Yalysheva, Kazakhstan
Al-Farabi Kazakh National University
Genotyping Cystic Echinococcosis in Kazakhstan to investigate a possible genotype – organ correlation and generate new epidemiological data
Dr. Jaime Amorim, Brazil
Universidade Federal do Oeste da Bahia
Purification of Zika virus non-structural proteins aiming viral pathogenesis studies
Dr. Michael Frimpong, Ghana
Kumasi Centre for Collaborative Research in Tropical Medicine
Rapid detection of Mycobacterium ulcerans by recombinase polymerase amplification
Dr. Theam Soon Lim, Malaysia
Universiti Sains Malaysia, Instittute for Research in Molecular Medicine
Novel monoclonal human antibodies for Zika Virus Nonstructural proteins
Dr. Rubens Monto Neto, Brazil
Oswaldo Cruz Foundation, René Rachou Research Centre, Laboratory of Molecular and Celular Biology
GoldLeish: novel phosphine-derived gold(I) complexes against antimony-resistant and -sensitive Leishmania parasites as drug candidates for leishmaniasis treatment
Dr. Hugo Perazzo, Brazil
Fundação Oswaldo Cruz / Instituto Nacional de Infectologia Evandro Chagas, LAPCLIN-AIDS
Validation of an algorithm using non-invasive methods for diagnosis of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in monoinfected HIV patients under combined antiretroviral therapy (c-ART) [HIV LiverTox Registry]
Dr. Cathy Samo, Kenya
University of Nairobi, College of Health Sciences School of Medicine – Anatomic Pathology Unit
Thymic morphological and functional characteristics among cases of fatal paediatric severe acute respiratory infections, a retrospective crossectional study
Dr. Kuldeep Sharma, India
National Institute for Research in Tribal Health, Jabalpur
To design and develop high sensitivity detection of MTB-Antigens using Immuno-LAMP to detect
Mycobacterium tuberculosis antigens directly from specimens/sputum
Mr. Sean Wasserman, South Africa
University of Cape Town, Division of Infectious Diseases and HIV Medicine, Dept. of Medicine
Colonisation with multidrug-resistant bacteria and C difficile in long-term care facilities in Cape Town, South Africa
Ms. Evelyn Wesangula, Kenya
Ministry of Health Kenya, Patient and Health Workers Safety Unit
Clean your hands, save a life
Dr. Francis Zeukeng, Benin
The International Institute of Tropical Agriculture (IITA), AgroEcoHealth Platform, Advanced Molecular Biology Laboratory
Proof of concept study: Are mosquitoes capable of picking up from their breeding environment and hosting the Mycobacterium ulcerans (Buruli ulcer etiological agent) in their bodies throughout their developmental stages?
Final Report: Zeukeng
Dr. Natalia de Miguel, Argentina
Instituto Tecnologico Chascomus (IIB-INTECH)
Epigenetic mechanisms in Trichomonas vaginalis: implications for gene expression, pathogenesis and drug discovery
Final Report: deMIGUEL
Dr. Jerome Dinga, Cameroon
Biotechnology Unit, Faculty of Science, University of Buea
Growth inhibition assay and proof-of-concept assessment of a chimeric UB05-09 antigen and a homologue in T. parva; TpUB05 in clinical malaria caused by P. falciparum
Ms. Yvonne Djieugoue, Cameroon
Service de Mycobactériologie, Centre Pasteur du Cameroun
An evaluation of the expression of catalase-peroxidase, an isoniazid-drug activating enzyme, and drug efflux pumps in clinical drug resistant and susceptible M. tuberculosis isolates
Dr. Balwant Godara, India
International Institute of Information Technology, Bangalore, India
Information and communications technologies to alleviate bottlenecks in diagnostics of infectious diseases
Dr. Vivek Gupta, India
Department of Pathology, Jawaharlal Nehru Medical College
Assessment of clinically suspected and unsuspected tubercular lymphadenopathy by PCR compared to non molecular methods in lymph node aspirates
Final Report: GUPTA
Ms. Augusta Kolekang, Ghana
College of Health
Capacity of health facilities to implement universal malaria diagnosis and treatment guideline in Ghana
Mr. David Nderu, Kenya
Analysis of Plasmodium falciparum Histidine Rich Protein-2 (pfhrp2) gene diversity in Kenya and its efect on malaria Rapid Diagnostic Tests (RDTs)
Dr. Jandeli Niemand, South Africa
Malaria Parasite Molecular Laboratory, Department of Biochemistry, Faculty of Agricultural and Natural Sciences, University of Pretoria
Functional genomics analyses of the differential susceptibility of early and late P. falciparum gametocytes to antimalarial compounds in order to aid drug discovery efforts
Final Report: NIEMAND
Dr. Cindy Shuan Ju Teh, Malaysia
Department of medical Microbiology, Faculty of Medicine, University of Malaya
Longitudinal study of the impact of changing trends in genotypes and phenotypes of carbapenem-resistant Klebsiella pneumoniae infection in a Tertiary Teaching hospital in Malaysia
Final Report: SHUAN.JU.TEH
Ms. Elizabeth Villasis, Peru
Laboratorio de Malaria, Laboratorio de Investigacion para el Desarrollo (LID), Universidad Peruana Cayetano Heredia
Functional assessment of monoclonal antibodies for their ability to block in vitro the invasion of Peruvian P. falciparum parasite isolates into erythrocytes
Final Report: VILLASIS
Dr. Yaw Afrane, Kenya
Kenya Medical Research Institute, Climate and Human Health Research Unit, Centre for Global Health Research
Impact of delayed malaria parasite clearance on malaria transmission in western Kenya
Dr. Amin Aqel, Jordan
Mu’tah University, Faculty of Medicine
Infections caused by Gram negative bacteria in the unfortunate Syrian refugees in Jordan, epidemiological and molecular study
Final Report: AQEL
Dr. Pascaline Fonteh, South Africa
University of Pretoria, Dept. of Biochemistry, Faculty of Natural and Agricultural Science
Improving the in vitro pharmacokinetic profile of malaria, TB and HIV drugs using nanotechnology
Final Report: FONTEH
Dr. Tinashe Gede, Zimbabwe
University of Zimbabwe College of Health Sciences, Department of Internal Medicine,
Evaluation of the feasibility and diagnostic accuracy of a point-of-care urinary lateral flow assay (Alere Determine LF-LAM) for diagnosis of tuberculosis among hospitalized, HIV-infected patients in Harare, Zimbabwe
Ms. Silvina Goenaga
Instituto Nacional de Enfermedades Virales Humanas “Dr. Julio I. Maiztegui”, Research Department,
Potential for co-infection of novel mosquito-specific flaviviruses to block human flaviviral disease agent infection and/or transmission in mosquitoes. In collaboration with the CDC, Ft. Collins, CO, USA
Final Report: GOENAGA
Mr. François Kiemde, Burkina Faso
Clinical Research Unite of Nanoro
Determination in vitro of Natural Killer cells cytotoxicity directed against erythrocytes infected by Plasmodium falciparum during pregnancy
Mr. Richard Kwizera, Uganda
Makerere University, College of Health Sciences, Infectious Diseases Institute, Department of Research
Estimation of prevalence of Aspergillus hypersensitivity in HIV patients post PTB treatment attending the Infectious Diseases Institute (IDI) clinic in Kampala, Uganda
Final Report: KWIZERA
Dr. John Libwea, Cameroon
Expanded Programme on Immunization, Central Technical Group, Department of Planning, Monitoring & Evaluation
Assessing the burden of otitis media (OM) in children 2 to 3 years of age and estimate the effect of pneumococcal conjugate vaccine (PCV-13) inclusion on OM in the Expanded Programme on Immunisations (EPI) in Cameroon
Final Report: LIBWEA
Dr. Laura Perez-Vidakovics, Argentina
Universidad Nacional de La Plata (UNLP), Departamento de Ciencias Biológicas, Instituto de Biotecnología y Biología Molecular, IBBM, CCT-CONICET-La Plata, Facultad de Ciencias Exactas
Role of autophagy in replication of Junin virus (JUNV)
Ms. Huldah C. Sang, Kenya
Kenya Medical Research Institute, Neglected Tropical Diseases Unit, Centre for Global Health Research
Identification and management of genital schistosomiasis and association with HIV amongst women of reproductive age in Rarieda district, western Kenya
Mr. Clovis Seumen, Cameroon
The Biotechnology Center/University of Yaoundé I, Molecular Parasitology and Disease Vectors Research Laboratory
Evaluation of the effect of Ascaris lumbricoides proteins on host immune response to MSP3 (malaria vaccine candidate) in BALB/c mice
Final Report: SEUMEN
Dr. Gbemisola Boyede, South Africa
Infectious Disease Clinic, Red Cross War Memorial Children’s Hospital
Validation of a new developmental screening tool for neurodevelopmental delays among HIV-infected South African children
Final Report: BOYEDE
Ms. Yagahira Castro Sesquen, Peru
Laboratorio de Investigación en Enfermedades Infecciosas, Universidad Peruana Cayetano Heredia
Novel nanotechnology for urine antigen detection in congenital Chagas disease
Dr. Admasu Mamuye, Ethiopia
Dept of Internal Medicine, School of Medicine, College of Health Sciences, Addis Ababa University
Utilizing point-of-care test for cryptococcal screening among HIV-infected persons in Ethiopia
Dr. João Marques, Brazil
Department of Biochemistry and Immunology, Institute for Biological Sciences, Universidade Federal de Minas Gerais
RNA Interference: a tool for identifying and controlling dengue virus and other arboviruses in insect vectors
Final Report: MARQUES
Mr. Erick Muok, Kenya
Schistosomiasis Research Unit, Center for Global Health Research, Kenya Medical Research Institute
Evaluation of schistosomiasis treatment efficacy and re-infection patterns in children co-infected with Schistosoma haematobium and S. mansoni in western Kenya
Fall 2012 Awardees
Dr. Soledad Negrotto, Argentina
Laboratorio Trombosis Experimental, Instituto de Medicina Experimental (IMEX), CONICET-Academia Nacional de Medicina
Understanding platelet-RNA virus interaction
Final Report: NEGROTTO
Dr. Samwel Odiwuor, Kenya
Medical Laboratory Sciences Mount Kenya University
Determination of Leishmania tropica diversity and distribution within sand flies in an endemic focus of cutaneous Leishmaniasis in Kenya
Dr. Philip Owiti, Kenya
Integrating HIV services for tuberculosis patients in Western Kenya: how well are we doing?
Final Report: OWITI
Dr. César Rodriguez, Costa Rica
Research Center for Tropical Diseases, Faculty of Microbiology, University of Costa Rica
Revealing novels aspects of cell wall synthesis and ß-lactam sensitivity in Salmonella enterica serovar Typhimurium: studies on the interactome of the periplasmic protease Tsp and the outer membrane lipoprotein NlpI
Final Report: RODRIGUEZ
Mr. Techalew Shimelis, Ethiopia
Hawassa University, College of Medicine and Health Sciences
Performance evaluation of three rapid diagnostic tests for detection of Cryptosporidium antigen in stool specimen from patients with HIV/AIDS
Final Report: SHIMELIS
Dr. Mohammad Sohail, India
University Department of Zoology, Vinoba Bhave University, Jharkhand
Investigation on the role of nitric oxide production and singe nucleotide diversity during malaria anemia for protective and diagnostic potential among malaria endemic population of Jharkhand
Final Report: SOHAIL
Spring 2012 Small Grant Awardees
Dr. Phuc Hong Le, Vietnam
National Institute of Hygiene and Epidemiology
An economic evaluation of the introductIon of Haemophilus influenzae type b vaccine In Vietnam, Including its impact on high-risk HlV-infected children
Final Report: LE
Dr. Peter Maturi Mwamba, Kenya
University of Nairobi, College of Health Sciences
Study of AF1q/CD44 expression status across the spectrum of Burkitt’s lymphoma (endemic v. sporadic v. epidemic)
Dr. Emmanuel Odjadjare, Nigeria
Western Delta University, Department of Microbiology and Biotechnology
Molecular epidemiology of Vibrio species isolated from environmental, food and clinical samples in a fast growing semi-urban town in the Niger Delta region of Nigeria
Final Report: ODJADJARE
Dr. Tseren-Ochir Erdene-Ochir, Mongolia
State Central Veterinary Laboratory
Studies on characteristics and distribution of avian influenza viruses in wild birds of Mongolia and genetic comparison avian influenza viruses isolated from North East Asia includes Mongolia and Korea
Final Report: ERDENE-OCHIR
Ms. Nikita Sahadeo, Trinidad
University of the West Indies
A high-throughput next-generation molecular study of viruses associated with suspected dengue cases in Trinidad and Tobago
Fall 2011 Small Grant Awardees
Dr. Alisone Githendu, Kenya
University of Nairobi, School of Medicine, Department of Human Pathology
Effects of depot medroxyprogesterone acetate on plasma and cervical lavage HIV viral load
Final Report: GITHENDU
Dr. Carlos Machain Williams, Mexico
Autonomous University of Yucatan, Arbovirology Laboratory, Regional Research Center (Hideyo Noguchi).
Importance of rodents as reservoir hosts of arthropod-borne viruses in Merida City, Mexico
Final Report: MACHAIN-WILLIAMS
Ms. Beth Mutai, Kenya
Kenya Medical Research Institute, Basic Science Laboratory
Burden of tick borne pathogens in patients with acute febrile illness in Kenya
Final Report: MUTAI
Ms. Guomkuo Mafopa Nadége, Cameroon
“Chantal Biya” International Reference Centre for Research and Management of HIV/AIDS
Quantification and importance of broad neutralizing antibodies in vertical transmission of HIV in Cameroon
Final Report: NADEGE
Dr. Braulio M. Valencia, Peru
Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical “Alexander von Humboldt, “Grupo de Investigacion de Leishmaniasis
Leishmania RNA virus as a possible determinant of pathogenicity in American Tegmentary Leishmaniasis: detection and quantification of viral load clinic samples
Final Report: VALENCIA
Spring 2011 Small Grant Awardees
Dr. Dodi Safari, Indonesia
Eijkman Institute for Molecular Biology
Identification of Streptococcus pneumonaie serotypes and detection of specific anti-polysaccharides antibodies in Indonesian population
Final Report: SAFARI
Ms. Vu Tra My Phan, Vietnam
Enteric Infections Group, Hospital for Tropical Diseases, Oxford University Clinical Research Unit
The prevalence and phylodynamics of norovirus, an agent of diarrhea, in symptomatic and asymptomatic children in Ho Chi Minh City, Vietnam
Final Report: MY PHAN
Dr. Tsira Chakhaia, Georgia
Epi-surveillance and Strategic Planning Department, National Center for Tuberculosis and Lung Diseases
Contact investigation for Tuberculosis in Georgia, Tblisi (Pilot Project)
Final Report: CHAKHAIA
Ms. Béatrice Dambaya, Cameroon
Chantal Biya International Reference Center (CBIRC)
Trim 5 a gene polymorphysm in Cameroonian infants: restriction to HIV infection, implication in disease progresson or protection
Final Report: DAMBAYA
Ms. Joanne Hassan, Kenya
Relationship between vaccine vial monitors and potency status of oral Polio virus vaccine among retrieved field samples in Kenya
Final Report: HASSAN
Dr. Miriam Rolan, Paraguay
Centro papa el Desarrollo de la Investigación Cientifica (CEDIC)
In vitro assays of 2,5-dihidroxibencil derivatives on Trypanosoma cruzi and Leishmania donovani
Final Report: ROLON
Fall 2010 Small Grant Awardees
Mr. Milner Mukumbwali, Zambia
Tstsee and Trypanosomosis Control Section, Department of Veterinary and Tsetse Control Service
Impact of aerial spraying against Glossina morsitans centralis on animal trypanosomosis in Sesheke and Shangombo Districts of Western Zambia
Dr. Neelika Malavige, Sri Lanka
University of Sri Jayawardanapura, Department of Microbiology, Faculty of Medical Sciences
Identifying biomarkers for predicting severe disease in dengue infections
Dr. K.E. Vandana, India
Katsturba Medical College, Department of Microbiology, Manipal
Detection and characterizations of metallo beta lactamase resistance among Gram negative bacilli and clinical epidemiology of infections in Indian tertiary care hospital
Ms. An Duy Duong, Vietnam
Hospital for Tripical Diseases, Tuberculosis Research Group
Mechanisms of cross-resistance to Fluoroquinolones in Mycobacterium tuberculosis
Mr. Stephen Kusi, Ghana
Kumasi Centre for Collaborative Research (KCCR), Department of Biochemistry and Biotechnology, KNUST
Detecting and quantifying Plasmodium falciparum in blood and tonsils: Towards an understanding of malaria-related oncogenesis
Final Report: KUSI
Spring 2010 Small Grant Awardees
Dr. Tavan Janvilisri, Thailand
Mahidol University, Department of Biology, Faculty of Science
Characterization of sporulation and spore germination of Clostridium difficile isolated from different host origins
Mr. Ephram Mekonnen, Ethiopia
Addis Ababa University, Department of Biology/Applied Genetics Stream
Modeling the impact of HIV/TB co-infection and environmental exposures on MTB infection outcomes: latent or active Tuberculosis
Mr. Marshall Munjoma, Zimbabwe
University of Zimbabwe, Department of Obstetrics and Gynecology
The impact of antiretroviral therapy on the genital shedding of herpes simplex virus type -2
Dr. César Ugarte-Gil, Peru
Universidad Peruana Cayetano Heredia, Laboratorios de Investigación Desarrollo
Detection and susceptibility testing for Tuberculosis in lymph node tissue using the MODS method
Dr. Sujit Pujhari, India
Post Graduate Institute of Medical Education and Research (PGIMER), Department of Virology
Significance of pattern recognition molecules (Toll like Receptors) in the Neuropathogenesis of Japanese encephalitis
Dr. Patricio Retamal, Chile
University of Chile, Department of Preventive Medicine, Faculty of Veterinary Sciences
Molecular epidemioloy of Salmonella enterica SV. Enteritidis strains isolated from wild birds, domestic animals and humans from Chile
Fall 2009 Small Grant Awardees
Ms. Marlinang D. Siburian, Indonesia
Mochtar Riady Institute for Nanotechnology
Molecular epidemiology of Hepatitis B virus in Minangkabaus sub-ethnic of West Sumatera, Indonesia
Final Report: SIBURIAN
Dr. Iskra Tuero, Peru
Universidad Peruana Cayetano Heredia, Inst. de Medicina Tropical Alesander von Humboldt, Laboratory of Immunology
TCR gd+ T cells: perforins/granulysins production with Leptospira
Dr. Marsia Gustiananda, Indonesia
Eijkman Institute for Molecular Biology
Prediction of T-cell epitopes of influenza A and the analysis of T-cell responses targeted to the proteome of influenza A virus in Indonesian population
Mr. Anthony Kebira, Kenya
Jomo Kenyatta University of Agriculture & Technology, Medical Microbiology
Evaluation of HIV evolution and its role in development of antiretroviral drug resistance, within a cohort
Final Report: KEBIRA
Dr. André Talvani, Brazil
Universidade Federal de Ouro Preto, Instituto de Ciências Exatas e Biológicas (ICEB II), Departamento de Ciências Biológicas
Inflammatory angiogenesis in the cardiac remodeling during experimental Chagas disease
Dr. Robert Paulino, Dominican Republic
Instituto Dominicano de Estudios Virologicos (IDEV)
Human Papilloma Virus (HPV) detection in men who have sex with men (MSM) in the Dominican Republic
Final Report: PAULINO
Spring 2009 Small Grant Awardees
Mr. Godwin Kwakye-Nuako, Ghana
University of Ghana Medical School, Department of Microbiology
Toxoplasmosis in Ghana: Seroprevalence study in the coastal population
Final Report: KWAKYE-NUAKO
Mr. Nicholas Kiulia, Kenya
University of Pretoria, Institute of Primate Research,Dept. of Medical Virology, Enteric Viruses Research Group
Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children under five years of age in a rural setting (Meru hospital) in eastern part of Kenya
Final Report: KIULIA
Ms. Katherine Torres, Peru
Universidad Peruana Cayetano Heredia, Instituto de MedicinaTropical ‘Alexander von Humboldt,’ Molecular Epidemiology Unit
Role of regulatory T-cells and their association with the clinical outcome of malaria infection (symptomatic and non-symptomatic individuals) in Peruvian Amazon
Final Report: TORRES
Dr. George M. Varghese, India
Christian Medical College, Department of Medicine and Infectious Diseases
Genotyping of Orientia tsutsugamushi from patients with scrub typhus
Final Report: VARGHESE
Ms. Pauline Byakika, Uganda
Makerere University, Faculty of Medicine, Department of Medicine
Pharmacokinetics and safety of artemether/lumefanitrinewhen administered concomitantly with Lopinavir/Ritonavir in HIV positive Ugandan patients with uncomplicated malaria
Fall 2008 Small Grant Awardees
Charmaine Mlambo, South Africa
University of the Witwatersrand, Clinical Microbiologyand Infectious Diseases
Molecular and epidemiological characterization of multidrug-resistant Mycobacterium tuberculosis isolates in Johannesburg, South Africa
Final Report: MLAMBO
Saradiya Chatterjee, India
Prof. Benjamin M. Pulimood Laboratories for Infection, Immunity and Inflamation
Clinico-epidemiologic and molecular characterization of metallo beta lactamases (MBLs) producing Pseudomonas aeruginosa causing nosocomial infections
Final Report: CHATTERJEE
Jobiba Chinkhumba, Malawi
Malaria Alert Centre, Department of Community Medicine,College of Medicine
Impact of HIV infection on the performance of malaria rapid diagnostic tests
Daniel Ojurongbe, Nigeria
Department of Medical Microbiology and Parasitology,College of Health Sciences,
Ladoke Akintola University of Technology
Plasmodium falciparum antifolate resistant alleles and associated opportunistic infection among HIV individuals on Cotrimoxazole prophylaxisin Osogbo, Nigeria
Final Report: OJURONGBE
Pamela Valva, Argentina
Laboratory of Molecular Biology, Pathology Division,Ricardo Guitierrez Children’s Hospital
Serum markers of liver injury in chronic hepatitis Cvirus infection
Final Report: VALVA
Spring 2008 Small Grant Awardees
Ifedayo Adetifa, The Gambia
Bacterial Diseases Programme, Medical Research Council(UK) Laboratories
A pilot study of nasopharyngeal carriage of Streptococcus pneumoniae in Nigerian children
Final Report: ADETIFA
Jackson Onyuka, Kenya
Biomedical Science and Technology, School of Public Health and Community Development
Evaluation of different methods for controlling fish-borne pathogenic microbes
Cristina Guerra-Giraldez, Peru
Dept. of Microbiology
School of Science, Universidad Peruana Cayetano Heredia
Adequate cultures of clinical isolates of Trichomonas vaginalis for molecular studies of virulence
Final Report: GUERRA-GIRALDEZ
Fall 2007 Small Grant Awardees
Dr. Diana Waturangi, Indonesia
Faculty of Biotechnology, Atma Jaya Catholic University
Detection of virulence genes and class 1 integron associated gene cassettes in Vibrio cholerae isolated from ice of street foods in Jakarta, Indonesia
Final Report: WATURANGI
Dr. Wanda Markotter, South Africa
Dept. of Microbiology and Plant Pathology, Faculty of Natural and Agricultural Sciences,
University of Pretoria
Diagnostics and molecular epidemiology of wildlife rabies in remote areas of the KwaZulu Natal province of South Africa
Final Report: MARKOTTER
Dr. Fanny Ita, Peru
Universidad Peruana Cayetano Heredia, Instituto de MedicinaTropical “Alexander von Humboldt”
HTLV-1-associated myelpathy/tropical spastic paraparesis in the Peruvian Andes
Final Report: ITA
Spring 2007 Small Grant Awardees
Dr. Florence Ogo, South Africa
Onderstepoort Veterinary Institute, Rabies Unit
Genetic charactersation of dog rabies virus isolates from Nigeria
Final Report: OGO
Dr. Shan Lv, China
Dept. of Vector Control, National Institute of Parasitic Diseases,Chinese Center for Diseases Control & Prevention
Intraspecific genetic differentiation of Angiostrongyluscantonensis based on the complete mitochondrial genome
Final Report: LV
Angela Carvalho Freitas, Brazil
Department of Epidemiology, School of Public Health,University of Sao Paulo
Modeling the impact of introducing the pertussis’ vaccine booster for adolescents and adults in Sao Paulo City, Brazil
Final Report: CARVALHO-FREITAS
Fall 2006 Small Grant Awardees
Department of Experimental Medicine, Tamilnadu Dr. MGR Medical University, India
Project: Divergent HIV strains circulating among the Intravenous Drug Users (IDU) in South India
Laboratório de Estudos Integrados em Bioquímica Microbiana Instituto de Microbiologia – Universidade Federal do Rio de Janeiro, Brazil
Project: Plant defenses against fungal pathogens
Healthmatch International, Nigeria
Project: Antiretroviral therapy use, clinical and virologic outcomes for a cohort of HIV–infected Adults in Mainland General Hospital, Lagos Nigeria
Final Report: ADEYEMI
Spring 2006 Small Grant Awardees
The Hashemite University, Jordan
Project: Reporting rate of occupational injuries and exposure to blood borne infections among Jordanian healthcare workers: A descriptive study
Khaled Mustafa Swaileh
Biology & Biochemistry Dept. Bireit University, Palestinian Territories
Project: Microbial health risks associated with consumption of untreated water from household roof catchment systems
Laboraorio de Biiologia Molecular Aplicada Facultad de siencias exactas Quimicas Y Naturales, Universidad nacional de Misiones, Argentina
Project: TNF-alpha promoter Single Nucleotide Polymorphisms (SNPs) and Human Papillomavirus (HPV) cervical infection in Guarani Indian women inhabiting the rainforest of Misiones, Argentina
Final Report: BADANO
Fall 2005 Small Grant Awardees
Department of Microbioloy, University of Venda, South Africa
Project: Drug resistance in HIV-1 Subtype C
Luis Brieba de Castro
Department of Biochemistry, CINVESTAV, Mexico
Project: Structural studies of the EhCP112 cysteine Proteease from Entamoeba histolytica
Azure Tariro Makadzange
University of Zimbabwe School of Health Sciences, Zimbabwe
Project: The appropriate management of cryptococcal meningitis in sub-Saharan Africa: A study of immediate vs. deferred anti-retroviral therapy in the treatment of cryptococcal meningitis with long term follow up to determine when it is safe to discontinue secondary prophylaxis against cryptococcal meningitis
Spring 2005 Small Grant Awardees
Gameleya Research Institute of Epidemiology and Microbiology, Russia
Project: Releasing of membrane-anchored proteins and its role in Listeria monotogenes virulence
Maria Ines Gismondi
Laboratory of Virology, Ricardo Gutierrez Children’s Hospital, Argentina
Project: Apoptosis markers related to pathogenesis of hepatitis C virus infection in pediatric patients
Viomedical Research Unit, Asociacion Benefica PRISMA, Peru
Project:Community-based epidemiologic study of Chagas’ disease in Arequipa, Peru
Fall 2004 Small Grant Awardees
Instituto de Biologia Celular y Molecular de Rosario, Departmento de Microbiologia, Argentina
Project: Molecular, genetic and biochemical characterization of Acyl-CoA carboxylase complexes of Mycobacterium tuberculosis: finding new drug targets for treating mycobacterial diseases
Hasan Bin Hamza
Department of Family Medicine, Aga Khan University, Pakistan
Project: Hepatitis survey in adults of Jam Kandah, Landhi District, Karachi, Pakistan
Department of Molecular Medicine and Haematology, University of the Witwatersrand Medical School, South Africa
Project: Nonprogressive HIV-1 subtype C infection – viral determinants
Spring 2004 Small Grant Awardees
Department of Microbiology, University of Venda for Science and Technology
Project:Molecular epidemiology of Entamoeba histolytica in the Venda region of South Africa, and anti-amebic activities of local medicinal plants
Final Report: AMIDOU
The Meccan Medical College and Allied Hospitals
Project: Molecular genotyping of Helicobacter pylori strains associated with gastric and duodenal ulcers using whole genome fingerprinting: Andhra Pradesh, South India
Cesar Henriquez Camacho
Instituto Medicina Tropical Alexander von Humboldt, Universidad Peruana
Project:Immune response in BALB/c mice to Bartonella bacilliformis infection
Fall 2003 Small Grant Awardees
Institute of Immunology, Zagreg, Croatia
Project: Mechanisms of apoptosis in 293HEK cells infected with hantaviruses
Final Report: MARKOTIC
Rodero, Laura Liliana
Departamento Micologia, Instituto Nacional de Enfermedades Infecciosas, Buenos Aires, Argentina
Project: Amino Acid Substitutions of 14 alfa demethylase (ERG11) in Fluconazole Resistant Cryptococcus neoformans clinical isolates
Final Report: RODERO
Singh, Mayengbam Pramotchand
Green Foundation, Imphal, India
Project: Situation and response assessment among sex workers in Manipur, 2003-04
Spring 2003 Small Grant Awardees
Dept. of Community and Family Medicine, The Chinese University of Hong Kong
Project: A pilot study of HIV counseling to increase willingness to receive premarital HIV testing among marriage license applicants in a rural area of China
Final Report: LIU
Nunez, Regina Sara
Institute of Tropical Medicine, Lima, Peru
Project: Recombinant Cysteine Proteinase B (rCPB) of Leishmania braziliensis as a vaccine candidate: immunoprotective evaluation in hamster as experimental model
Leangaramgul, Preecha & Sapsutthipas, Sompong & Virunchaichot, Kraiwut
Medical Biotechnology Center (MBC), Nonthaburi, Thailand
Project: The neutralizing activity of the prime-boost regimen with rBCG-E12 and rDIs-E12 candidate vaccine
Final Report: LEANGARAMGUL
Karugi, Andrew Karani
International Center for Reproductive Health Research Lab, Coast Provincial General Hospital, Mombasa, Kenya
Project: Cytology in the diagnosis of bacterial vaginosisis
Fall 2002 Small Grant Awardees
Silvia Graciela Correa, PhD
Immunologia, Departamento de Bioquimica Clinica, Facultad de dCiencias Quimicas. Universidad Nacional de Cordoba
Project: Study of the mechanisms of weight loss, anorexia and hepatic injury in Candida albicans infection under stress conditions
Final Report: CORREA
John G. Ayisi, MSc (PhD pending)
Centre for Vector Biology & Control Research, Kenya Medical Research Institute
Project: An evaluation of the effectiveness of intermittent preventative treatment with sulfadoxine-pyrimethamine for malaria in pregnancy in Kenya
Alex K. Owusu-Ofori, MBChB
Department of Child Health and Microbiology, School of Medical Sciences, Kwame Nkrumah University of Science and Technology
Project: The epidemiology and prevention of blood borne pathogen exposure among health care workers in Ghana
Final Report: OWUSU_OFORI
Spring 2002 Small Grant Awardees
Ms. Dao-Yu Chao, MS
Department of Epidemiology, School of Public Health, National Taiwan University, Taiwan
Project: A family study for searching genetic changes of dengue virus serotype 3 in Taiwan
Mr. Simon Kamau Kariuki, MPhil
Kenya Medical Research Institute / Center for Vector Biology and Control Research (KEMRI/CVBCR), Kenya
Project: Effects of permethrin-treated bednets on acquisition of antibodies Plasmodium falciparum variant surface antigens (VSAs) in pregnant women in an area of perennial malaria transmission in western Kenya
Dr. Pablo Cesar Baldi, PhD
Instituto de Estudios de la Inmunidad Humoral, Universidad de Buenos Aires, Argentina
Project: Characterization of virulence factors secreted by Brucella species: amino acid sequences, triggering stimuli, cellular effects and recognition by the immune system of the host
Fall 2001 Small Grant Awardees
Faculty of Physical and Natural Sciences, National University of Cordoba, Argentina
Project: Isolation of microsatellite loci for population genetic studies of the natural reservoir Junin virus, Calomys musculinus.
Nicolass Gey van Pittius
Faculty of Health Sciences, University of Stellenbosch, South Africa
Project: A molecular and epidemiological investigation into the factors contributing to the prevalence of re-infection and the paucity of dual infections in a community with a high incidence of tuberculosis.
College of Medicine, University of Ibadan, Nigeria
Project: Identification of candidate single nucleotide polymorphisms (SNPs) in plasmodium falciparum isolates (R) showing false negative results using the Parasight – F dipstick.
Final Report: GBOTOSHO
Spring 2001 Small Grant Awardees
Center for DNA Fingerprinting and Diagnostics, Hyderabad, India
Project: Automated sequencing, functional analysis and comparative genomics of selected AFLP markers from Mycobacterium tuberculosis isolates in India.
Silvia Viviana Nates
Institute of Virology, University of Cordoba, Argentina
Project: Picobirnavirus molecular biology: diagnosis and genomic characterization of strains circulating in Argentina.
Virology Group, International Centre for Genetic Engineering and Biotechnology, India
Project: Study of the immunogenicity of DNA vaccines encoding the Gepatitis E Virus major capsid protein.
Fall 2000 Small Grant Awardees
Willy K. Tonui
Centre for Biotechnology Research and Development, Kenya Medical Research Institute
Project: Evaluation of Leishmania donovani derived Lipophosphoglycan as a candidate vaccine against Viceral Leishmaniasis in Murine Models.
Thanh Hoa Le
Molecular Parasitology Unit, Queensland Institute of Medical Research, Australia
Project: Molecular-based diagnosis and taxonomic studies on common parasitic disease caused by Paragonimus, Clonorchis/Opisthorchi, Fasciola and Schistoma in Vietnam using mitochondrial sequences as genetic markers.
Centro Internacional de Entrenamiento e Investigaciones Medicas, Colombia
Project: Screening for malaria in blood donors from Cali, Colombia. A comparison of PCR and IgG and IgG Elisa.
Spring 2000 Small Grant Awardees
Centre of DNA Fingerprinting and Diagnosis, India
Project: High resolution digital fingerprinting and development of an epidemiological database of Mycobacterium tuberculosis.
Center for Vctor Biology and Control Research, Kenya Medical Research Institute
Project: Glycophorin phenotype distribution and prevalence of glycophorin A independent Plasmodium falciparum parasites in Kombewa, Western Kenya.
Instituto de Medicina Tropical “Pedro Kouri” Cuba
Project: Isolation, identification and characterization of the Cuban Hepatitis E virus strain.
Fall 1999 Small Grant Awardees
Department of Microbiology, Parasitology and Immunology, School of Medicine, University of Buenos Aires, Argentina
Project: Epidemiological Studies of Vibrio cholerae (1992-1999) isolates in Argentina.
Biotechnology Department, Pasteur Institute of Iran
Project: Screening Iranian H. pylori isolates for cytotoxin (vacA) and its associated gene product (cagA)
Spring 1999 Small Grant Awardees
Blanca Ines Restropo
Corporación para Investigaciones Biológicas, Colombia
Project: Development of an immunoassay for neurocysticercosis: Phase II – Characterization of diagnostic epitopes.
Department of Infectious Diseases, Clinics of Samara State Medical University, Russia
Project: Hantavirus infection in men and rodents in the Samara region, European Russia.
Centre for Biotechnology Research and Development, Kenya Medical Research Institute
Project: Evaluation of Leishmania donovani derived lipophosphoglycan as a candidate vaccine against visceral leishmaniasis in murine models.
Fall 1998 Small Grant Awardees
US Army Medical Research Unit, Kenya
Project: Comparative study of the Kirby Bauer Antimicrobial Susceptibility Testing vs. a Modified Stokes Method using the Mastring-S Multidisks
Institute of Public Health, Albania
Project: Hepatitis C among chronic and polytransfused patients in Albania
Centre for Microbiology Research, Kenya Medical Research Institute
Project: Prevalence of resistance to b-lactam antibiotics among clinical isolates of gram negative bacteria
Blanca Ines Restrepo, Colombia
Molecular Parasitology Laboratory, Corporación para Investigaciones Biológicas
Project: Development of an immunoassay for neurocysticercosis: Phase I – Identification of diagnostic epitopes
1995 Small Grant Awardees
Charles W. Huskins, USA
Division of Infectious Diseases, Children’s Hospital
Project: Reduing Nosocomial Perinatal Infections in Demonstration Hospitals in Colombia Using Quality Improvement Methods.
Anna Przondo-Mordarska, Poland
Department of Microbiology, University of Medicine
Project: Hospital Infection Control in Wroclaw
Jorge Sanchez, Peru
Instituto de Medicina Tropical “Alexander von Humboldt”, Universidad Peruana Cayetano Heredia
Project: Training of fellows in epidemiology and laboratory technology related to HIV and other STDs to improve laboratory capability, intervention program in Lima, Peru
Dr. Aaruni Saxena, India/Germany
Department of General Medicine, Clinic Hilden, Düsseldorf
Dr. Saxena will conduct his research in collaboration with scientists from the Infectious Diseases Divisions in Basel, Switzerland.
Dr. Elhadj Ibrahima Bah, Guinea
Maladies Infectieuses et Tropicales, Université de Conakry
Dr. Bah will conduct his research in collaboration with scientists from the Infectious Diseases Divisions in Geneva, Switzerland.
Dr. Mehtap Simsek, Turkey
Infectious Diseases and Clinical Microbiology Dept., Haseki Training and Research Hospital
Dr. Simsek will conduct his research in collaboration with scientists from the Infectious Diseases Divisions in Bern, Switzerland.
Dr. Gebreselassie Hiwot Mamo, Ethiopia
Addis Ababa University Collage Of Health Science Department Of Internal Medicine
Dr. Hiwot Mamo will conduct her research in collaboration with scientists from the Infectious Diseases Divisions in Bern, Switzerland.
Final Report: MAMO
Dr. Botond Lakatos, Hungary
Saint Laszio Hospital, Department of Infectious Diseases
Dr. Lakatos will conduct his research in collaboration with scientists from the Infectious Diseases Divisions in Basel, Switzerland.
Final Report: LAKATOS
Dr. Dzmitry Viktaravich Piskun, Belarus
Belarusian State Medical University
Dr. Piskun will conduct his research in collaboration with scientists from the Infectious Diseases Divisions in St. Gallen, Switzerland.
Ms. Natalia Rodriguez, Colombia
Biological Sciences, Universidad de Los Andes
Ms. Rodriguez will conduct her research in collaboration with scientists from the Infectious Diseases Divisions in Geneva, Switzerland.
Fall 2009/10 Awardee
Dr. Andrea Moldovan, Romania
University of Medicine and Pharmacy, Tg. Mures, Clinic of Infectious Disease,
Dr. Moldovan conducted her research in collaboration with scientists from the Infectious Diseases Divisions in Geneva, Switzerland.
Fall 2008 Awardee
Dr. Alain Kenfak, Cameroon
General Hospital of Yaoundé
Dr. Kenfak conducted his research in collaboration with scientists from the Infectious Diseases Divisions in Lausanne, Switzerland.
Final Report: KENFAK
Fall 2007 Awardees
Dr. Juan Carlos Ambrosioni Czyrko, Argentina
Infectious Diseases “Francisco J. Muñiz” Hospital, Infectious Diseases Department
Dr. Czyrko conducted his research in collaboration with scientists from the Infectious Diseases Divisions in Geneva, Switzerland.
Dr. Marina Macedo-Viñas, Uruguay
Universidad de la República, Facultad de Medicina, Départmentde Bactériologie et Virologie
Dr. Macedo-Viñas conducted her research in collaboration with scientists from the Infectious Diseases Divisions in Geneva, Switzerland.
Fall 2006 Awardees
Ms. Zsuzsanna Barcsay, Romania
“Victor Babes” Clinincal Hospital of Pneumophtysiology and Infectious Diseases
University of Medicine & Pharmacy
Ms. Barcsay conducted her research in collaboration with scientists from the Infectious Diseases Divisions in Basel, Switzerland.
Dr. Rafael Perdomo Diaz, Venezuela
University Hospital of Caracas Venezuela, Intensive Care Unit
Dr. Diaz conducted his research in collaboration with scientists from the Infectious Diseases Divisions in Geneva, Switzerland.
Fall 2005 Awardees
Nobre Vandack, Brazil
Internal Medicine Division, Medical School, Federal University of Minas Gerais, Brazil
Dr. Vandack conducted his research in collaboration with scientists from the Infectious Diseases Divisions in Geneva, Switzerland
Final Report: NOBRE
Nhung Tuyet Vo Thi, Vietnam
Public health Department, Pasteur Institute in Ho Chi Minh City
Dr. Thi conducted her research in collaboration with scientists from the Infectious Diseases Divisions in Zurich, Switzerland.
Fall 2004 Awardees
Infectious Diseases Clinic, Clinical Care Center, University of Nis, Serbia & Montenegro
Dr. Djordjevic conducted her research in collaboration with scientists from the Infectious Diseases Divisions in Geneva, Switzerland
Final Report: DJORDJEVIC
Vladivostok Medical University, Russia
Dr. Martynova conducted her research in collaboration with scientists from the Infectious Diseases Divisions in Bern, Switzerland.
Final Report: MARTYNOVA
Fall 2002 Awardees
Dr. Andres Pascual, MD
Fundacion Centro de Estudios Infectologicos, Buenos Aries, Argentina
Dr. Pascual conducted his research in collaboration with scientists from the Infectious Diseases Divisions in Lausanne, Switzerland.
Final Report: PASCUAL
Dr. Dongmi Li, MD, MSc
The Clinical Laboratory of Shantou Central Hospital, Shantou, Guangdong Province, China
Dr. Li conducted her research in collaboration with scientists from the Infectious Diseases Divisions in Geneva, Switzerland.
Dr. Chaiwat Ungsedhapand, MD
HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand
Dr. Ungsdedhapand conducted his research with scientists from the Infectious Diseases Divisions in Basel, Switzerland.
2017 ISID/ESCMID Fellowship Awardees
Mr. Joseph Michael Oduor, Kenya
Institute of Primate Research, Nairobi
Complete genome analysis of lytic phages and identification of hypothetical phage proteins targeting major protein complexes of Staphylococcus aureus. In collaboration with the University Helsinki, Finland.
Mr. Deepjyoti Paul, India
Dept. of Microbiology, Assam University, Silchar
Analysis of the burden of antibiotic resistance in E. coli associated with gut carriage and bacteraemia’s in Northern India. In collaboration with the School of Medicine, Institute of Infection and Immunity, Cardiff University, UK.
2016 ISID/ESCMID Fellowship Awardees
Dr. Janine Seetahal, Trinidad and Tobago
The University of the West Indies
The identification of new, emerging and endemic viruses in the bat population of Trinidad and
Tobago. In collaboration with theInstitute of Biodiversity, Animal Health & Comparative Medicine, University of Glasgow, United Kingdom.
Final Report: SEETAHAL
Dr. Md. Akhtar-Uz-Zaman, Bangladesh
Rajshahi Medical College
Molecular epidemiology and spread dynamics of Carbapenem and Cephalosporin resistant
Enterobacteriaceae clones inside and outside of hospital settings
Molecular epidemiology and dissemination ecology of antibiotic resistant Acinetobacter baumannii clones inside and outside of Bangladeshi hospital settings. In collaboration with the Uppsala University, Sweden.
2014 ISID/ESCMID Fellowship Awardees
Mr. Juan Farizano, Argentina
INSIBIO (Instituto Superior de Investigaciones Biológicas), Universidad Nacional de Tucumán
Development and optimization of attenuated bacterial vaccines for the control of Salmonella infection: Effect of RcsCDB system in the fimbrial genes expression. In collaboration with the Departamento de Genética, Facultad de Biología, Universidad de Sevilla, Sevilla, Spain.
Final Report: FARIZANO
Dr. Refath Farzana, Bangladesh
Dept. of Microbiology, Kumudini Women’s Medical College and Dept. of Microbiology, Dhaka Medical College
Molecular epidemiology and dissemination ecology of antibiotic resistant Acinetobacter baumannii clones inside and outside of Bangladeshi hospital settings. In collaboration with the Uppsala University, Sweden.
Final Report: FARZANA
2013 ISID/ESCMID Fellowship Awardees
Dr. Syed Hani Abidi, Pakistan
Dept of Biological and Biomedical Sciences, Aga Khan University
Epitope evolution of HIV in genetically distant populations. In collaboration with the Nuffield Dept of Medicine, John Radclife Hospital, Oxford, UK
Final Report: ABIDI
Dr. Rodrigue Mintsa, Gabon
Dept of Parasitology-Mycology, Faculty of Medicine, University of Health Science
Schistosomiasis in Estuaire province of Gabon: What is the situation? In collaboration with the Université de Pergignan, Perpignan, France.
2012 ISID/ESCMID Fellowship Awardee
Dr. Isaac Clement, Nigeria
Ambrose Alli University, Department of Zoology, Tropical Disease Research Unit
Human African trypanosomiasis in Nigeria: identification of animal reservoir hosts and characterisation of the tsetse fly vector. In collaboration with the University of Glasgow, United Kingdom.
Final Report: CLEMENT
2011 ISID/ESCMID Fellowship Awardees
Dr. Josephine Siregar, Indonesia
Eijkman Institute for Molecular Biology
Phenotypic analysis of atovaquone resistant Plasmodium berghei mutants.
In collaboration with scientists from Erasmus MC University in Rotterdam, Netherlands.
Final Report: SIREGAR
Dr. Fernanda Ludolf Ribeiro, Brazil
Centro de Pesquuisa René Rachou FIOCRUZ/MG, Cellular and Molecular Parasitology
Profiling the humoral immune response to Schistosoma mansoni using a new immunoproteomic approach protein microarray.
In collaboration with scientists from the University of Nottingham, School of Pharmacy, Nottingham, UK.
Final Report: LUDOLF
2010 ISID/ESCMID Fellowship Awardee
Philip Anochie, Nigeria
Nigerian Institute of Medical Research, Microbiology Division
Genotype analysis of mycobacterium tuberculosis isolates.
In collaboration with scientists from the S. Raffaele Scientific Institute, Emerging Bacterial Pathogens Unit in Milan, Italy.
Final Report: ANOCHIE
2013 ISID Fellowship Awardees
Dra. Maria de las Mecedes Pescaretti, Argentina
CONICET, PROIMI-INSIBIO – Universidad Nacional de Tucumán
Study of the secretion flagellar proteins in the rcsC11 mutant to serve as a model of vaccine against Salmonella typhimurium. In collaboration with the University of Utah, Salt Lake City, USA.
Final Report: PESCARETTI
Mr. Johnson Mosoko Moliki, South Africa
Department of Molecular and Cell Biology, University of Cape Town
Skills development and technology transfer to investigate the molecular mechanisms of regulation of primary epithelial cell tight junctions of the female genital tract by contraceptives, hormones and HIV-1. In collaboration with McMaster University, Hamilton, Ontario.
Final Report: MOLIKI
2012 ISID Fellowship Awardee
Dr. Elyara Maria Soares, Brazil
Universidade de São Paulo, Faculdade de Ciéncias Farmaceuticas de Ribeirão, Dept. de Analises Clinicas, Toxicologicas e Bromatologicas
Leukotriene signaling and immunoregulation in postpartum Streptococcus infection. In collaboration with the University of Michigan, Ann Arbor, USA
Final Report: SOARES
2011 ISID Fellowship Awardees
Mr. Nicholas Kiulia, Kenya
Institute of Primate Research, WHO Collaborating Center
Molecular Characterization of Cryptosporidium isolates in captive olive baboon in Kenya. In collaboration with the Centers for Disease Control and Prevention in Atlanta, GA, USA.
Final Report: KIULIA
Dr. Kamlesh Gidwani, India
Banaras Hindu University, Institute of Medical Services, Department of Medicine
Immune response of humans to sand fly P. argentipes saliva: Western blot approach to identify novel salivary peptides with serum of asymptomatic infection in VL. In collaboration with the London School of Tropical Medicine, UK.
Final Report: GIDWANI
2010 ISID Fellowship Awardees
Dr. Erdenebileg Narnygerel, Mongolia
FIRE – Flagstaff International Relief Effort
Study on prevalence of blood borne infections among Mongolian health care workers. In collaboration with the National Institutes of Health in Bethesda, MD, USA
Dr. Micah Oyaro, Kenya
Kenya Medical Research Institute(KEMRI)
Molecular epidemiology and functional characterization of Hepatitis B and C viruses isolated from drug abusers in Kenya. In collaboration with the University of Witwatersrand, Department of Internal Medicine, South Africa.
2009 ISID Fellowship Awardees
Ms. Rosa Ramírez Bartutis, Cuba
Laboratorio deBiologíaMolecular, Departamento de Virología, Instituto MedicinaTropical “Pedro Kourí”
Characterization of immune response elicited by dengue 2virus recombinant NS3 protein immunized with dengue 4 virus recombinant E protein in mice. Research will be done at the Laboratóriode Genómica Estrutural Instituto de Biofisica Carlos Chagas Filho, Centro de Ciéncias da Saúde, Brazil.
Final Report: BARTUTIS
Ms. Lilian Ogonda, Kenya
Kenya Medical Research Institute(KEMRI)
Expression of FeyRIIa, FeyIIa, FeyRIIIa and Fey RIIb on monocytes of children after treatment for severe malaria. Research will be done at Pennsylvania State University College of Medicine,USA
2008 ISID Fellowship Awardees
Ines Badano, Argentina
University of Pennsylvania, USA
Analysis of Ethnic Differences in the Distribution ofTNF-a SNPs and Human Papilloma virus (HPV) Infection
Final Report: BADANO
Elkin Lemos Luengas, Colombia
University of Toronto, Canada
The economic impact of introducing HIV/AIDS guidelineinto Colombian National Drug Formulary: Costs-effectiveness and budget-impact analysis
Final Report: LEMOS
2007 ISID Fellowship Awardee
Dr. Radmilla Mirzayeva, Azerbaijan
Rotavirus Vaccine Program, PATH- Europe
Training to perform testing for Rotavirus infection using ELISA method and strain characterization using RT-PCR method in HPA, EVU Laboratory in London
2006 ISID Fellowship Awardees
Dr. Mateja Jankovic, Croatia
University Hospital for Infectious Diseases “Dr. Fran Mihaljevic”
Mechanisms of apoptosis by pathogenic hantaviruses
Dr. Luis Adrian, Argentina
Laboratorio de Arbovirus, Instituto de Virologia – F.C.M.-UNC
Investigation of avian amplifying hosts and mosquito vectors of a novel epidemic strain of St. Louis encephalitis virus (SLEV,Flaviviridae) isolated in Argentina
2005 ISID Fellowship Awardees
Maria Eugenia Alvarez
Department of Immunology, Hematologic Research Institute, National Academy of Medicine, Argentina
Project: Characterization of host response during Mycobacterium tuberculosis infection by gene expression profiling
Ms. Alvarez will conduct her research in collaboration with the TB Center of the Public Health Research Institute, New Jersey, USA.
Varsha Atul Potdar
Department of Retrovirology, National Institute of Virology, Pune, India
Project: Application of sensitive methodologies for detection of transmitted HIV drug resistance
Dr. Potdar will conduct his research in collaboration with the Centers for Infection, Heatlh Protection Agency, London, England
2004 ISID Fellowship Awardees
Department of Applied Microbiology, Nnamdi Azikiwe University
Project: Molecular characterization of virulence factors of five isolates of Cryptotrichosporon anacardiense (CBS 9549, CBS 9550, CBS 9551, CBS 9552 and CBS 9553), a new basidiomyceteous yeast genus from Nigeria
Dr. Okoli will conduct his research in collaboration with Yeshiva University, Albert Einstein College of Medicine in New York, USA.
Final Report: OKOLI
Project: Development of the strategy and elaboration of the detailed project for treatment of patients with Multi-drug Resistant Tuberculosis (MDR-TB) in the specific context of Azerbaijan
Dr. Mirzayev will conduct his research in collaboration with Partners in Health in Boston, Massachusetts, USA.
Final Report: MIRZAYEV
2003 ISID Fellowship Awardees
The Public Health Research Institute, Newark, New Jersey, USA
Project: Molecular epidemiology of Nigerian strains of Methicillin resistant Staphylococcus aureus
2002 ISID Fellowship Awardees
Dr. Dhrubaa Ghosh, PhD, MSc
Department of Microbiology, Virology, All India Institute of Medical Sciences, India
Project: Production of antibodies to recombinant G proteins of Indian isolates of RSV for detection and characterization of viruses
Dr. Ghosh will conduct her research in collaboration with scientists at the Department of Pediatrics/Microbiology, University of Alabama at Birmingham, Alabama, USA.
2001 ISID Fellowship Awardees
Marco Canales, Peru
Project: Technology transfer for parasitic disease diagnostics
This research was done at the McGill Centre for Tropical Diseases, Montreal, QC, Canada
Mariana Gisela Bego, Argentina
Project: Development of recombinant hantavirus antigens for serologic diagnosis with homologous serotype
Ms. Bego did her research at the University of Nevada, Reno, Nevada, USA
2000 ISID Fellowship Awardees
David Kateete, Uganda
Project: Investigation of T. Burcei prenylated protein methyltransferase (PPMTase) as a potential therapeutic target
Dr. Kateete’s research was conducted at the University of Washington, Seattle, Washington, USA
Salih Gosoglu, Turkey
Project: Molecular epidemiology of invasive Salmonella typhi in Southeast Turkey
Dr. Gosoglu conducted this research at McMaster University, Ontario, Canada
Sanaa Kamal, Egypt
Project: Specific cellular responses and cytokine patterns in patients with acute Hepatitis C virus co-infected with Schistosomiasis: Correlation to outcome of infection
Dr. Kamal worked at the Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
1999 ISID Fellowship Awardee
Papa Gallo Sow, Senegal
Project: HIV screening, testing clinic
Dr. Sow’s research was done at the Francois-Xavier Bagnoud Center, New Jersey, USA
1998 ISID Fellowship Awardees
Branca Bedenic, Croatia
Project: Biochemical and genetic characterization of extended spectrum beta-lactamesis from Zagreb, Croatia
Dr. Bedenic worked at The University Hospital Maastricht, The Netherlands
Pauline Mwinzi, Kenya
Project: Effect of Schistosomiasis and HIV co-infection on cellular and humoral responses to HIV and schistosomal crude and recombinant antigens
This project was carried out at the U.S. Center for Disease Control and Prevention in Atlanta, Georgia, USA
Antibiotic resistance (ABR) is a major public health issue worldwide and innovative approaches to tackling resistant bacteria in humans, animals and the environment are urgently needed. For many years, the Institut Mérieux and its entities have been committed to the fight against antibiotic resistance and to the control of the spread of resistant infections. In order to provide an incentive for promising young investigators working in the field of ABR, Institut Mérieux allocates several awards worldwide to researchers or clinicians at the beginning of their carrier in recognition of a major achievement having significant impact on the handling of ABR.
In 2018, Institut Mérieux and the International Society for Infectious Diseases awarded a joint Young Investigator Award of €10,000 Euros to an awardee during the 18th International Congress on Infectious Diseases/XVIII Congreso SADI which took place in Buenos Aires, Argentina, March 1 to 4, 2018. Recognizing that the rising threat of AMR requires a multisectoral “One Health” approach, applications from young investigators from the human, veterinary, and environmental fields will be considered.
ISID and Pfizer IGL&C collaborated in 2014 to offer a grant opportunity in the area of adult vaccination. ISID and Pfizer’s goal is to decrease health disparities by increasing access to or use of vaccinations by adults either individually or by population in low- and middle-income countries.
The consortium – composed of members of four public health and veterinary institutes – has the overall goal of increasing vaccination coverage among mobile pastoralists in Central Africa. In Chad with its high proportion of pastoralists, research and implementation partners have gained experience in well reaching pastoralists with joint human and animal vaccination campaigns, but a sustained strategy still needs to be better described before translation to policy. We hypothesize that the introduction of an assessed adult vaccination scheme will further increase the demand of pastoralists for vaccination services and lead to more frequent utilization of a mix between mobile, outreach and established fixed vaccination infrastructure. Given that one fifth of pastoralists regularly cross the country borders, Chad will initiate an exchange with its neighboring countries on how to serve pastoralist communities and on the appropriate vaccination scheme including adult vaccination – among the ‘lost-outs’. Main beneficiaries are the pastoralists in remote zones as well as the vaccination services. This operational research will facilitate vaccination campaigns between the health and veterinary sectors in three zones and two years. The campaigns are assessed with qualitative and quantitative approaches regarding the knowledge and perceptions on adult vaccination; randomized surveys will indicate the achieved coverage of women (TT2+) and an in-depth follow-up of few families will further show whether the overall demand to vaccination could be increased when other adult vaccines are added to the schedule. We will disseminate our results to all stakeholders to further explore how vaccinations can be sustainably delivered to these hard-to-reach communities.
The overall goal is to develop the Strategic Immunization Geo-temporal Mapping Application (SIGMA), a computational modelling tool to help decision makers: (1) forecast temporal demand for current and future adult immunizations, in a given country, in different parts of the country, and for each immunization location. (2) Determine the number and characteristics of adults that are reachable by current immunization locations and strategies in any given country. (3) Plan the locations and operating characteristics of various immunization strategies (e.g., outreach, campaigns, and other strategies) that are needed to supplement the fixed immunization locations. (4) Estimate the costs and cost-effectiveness of different adult immunization strategies from estimated demand scenarios. (5) Develop guidelines for adult vaccination use, to anticipate demand and to secure appropriate funding. (6) Demonstrate how robust these answers and solutions are to varying conditions (e.g., costs, population migration, mortality, and compliance with immunization). The key objectives of this project are to develop an initial version of SIGMA and utilize SIGMA for a pilot country (Mozambique) to evaluate the immunization logistics for a currently implemented adult vaccine (tetanus) and a planned adult vaccine (HPV). To evaluate the utility of SIGMA at the end of the project period, our team will convene a focus group of potential SIGMA users to evaluate and provide feedback on.
The scope of adult immunizations in many developing countries currently centers on a handful of vaccine-preventable diseases, but these vaccines have had limited reach within their target populations. Under this work, we will conduct an assessment of adult immunization-delivery scenarios in both low- and middle- income countries, with a focus on maternal immunizations. We will examine market requirements, program priorities, and user needs. We will identify possible constraints that may limit coverage of existing and future adult vaccines and map selected constraints to innovative packaging and delivery technologies that may help to optimize adult, particularly maternal, vaccine coverage. We will work with a variety of individual experts, but do not anticipate pursuing institutional collaborations. Instead, we will leverage the strength of PATH’s network of country offices to conduct the needs assessment.
Overall, the project aims to increase the accessibility and use of vaccines to prevent some communicable diseases such as influenza, rubella, tetanus, and hepatitis B in low- and middle-income countries in Southeast Asia period 2015-2017. The project will offer opportunities for researchers in institutions and agencies involved in improving capacity in research of adult vaccination immunization.
A multi-country, prospective and community-based study will be carried out over three years (tentatively 2015-2017). Pre- and post- evaluation design and community-based randomized control trials (RCT) will be applied in two Southeast Asian countries (Vietnam, Lao PDR).
Specifically, the outcome of the project aims to decrease health disparities by evidence-based novel interventions for accessing vaccination against influenza in Vietnam and Lao PDR. Vietnam and Lao PDR will implement health education interventions; at the same time Vietnam will implement a health service intervention in order to address barriers to vaccination access in each of their respective countries and localities. In addition, at least, two papers will be submitted to international peer-reviewed journals at the end of the project.
In response to the tragic outbreak of Ebola virus disease in West Africa, ISID stepped in to offer travel grants to individuals to enable them to attend one of the US Centers for Disease Control and Prevention (CDC) safety training courses to be prepared to work in an Ebola Treatment Unit in West Africa. The CDC course ran from October 2014 to March 2015. ISID received assistance from GlaxoSmithKline and the Niles Foundation.
Awards were made to individuals who joined the training at the CDC and went on to work in Liberia, Sierra Leone and Guinea. Awardees hailed from USA, UK, Brazil, Austria, Cuba, Germany, Pakistan, Canada, Nigeria, Saudi Arabia and Sierra Leone.
Douglas H. Hamilton, MD, PhD, Anniston/CDC Ebola Safety Training Course Director, sent the following thank you to ISID:
On behalf of the entire ETU Safety Training Team I want to thank you for your support of CDCs course. To date, 480 healthcare workers have completed the course in Anniston, AL and have learned the principles of infection prevention and control needed to work safely in an ETU setting. I know many of our international participants were able to participate in the training thanks to the travel grants provided by ISID. It has been an honor and a privilege to meet and help prepare healthcare workers to operate safely in an ETU environment and we could not have done this without the support of partners such as ISID.